RBM8A Antikörper (AA 79-112)

Produktnummer ABIN6242599

Produktdetails anti-RBM8A Antikörper

Target: RBM8A (RNA Binding Motif Protein 8A (RBM8A))

Bindungsspezifität: AA 79-112

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser RBM8A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Homologie: X, B, Rat

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This RBM8A antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 79-112amino acids from the Central region of human RBM8A.

Klon: RB49687

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Details zu RBM8A

Target: RBM8A (RNA Binding Motif Protein 8A (RBM8A))

Andere Bezeichnung: RBM8A (RBM8A Produkte)

Synonyme: BOV-1A antikoerper, BOV-1B antikoerper, BOV-1C antikoerper, C1DELq21.1 antikoerper, DEL1q21.1 antikoerper, MDS014 antikoerper, RBM8 antikoerper, RBM8B antikoerper, TAR antikoerper, Y14 antikoerper, ZNRP antikoerper, ZRNP1 antikoerper, 2310057C03Rik antikoerper, AA673428 antikoerper, Rbm8 antikoerper, RBM8A antikoerper, rbm8 antikoerper, rbm8a antikoerper, rnp-5 antikoerper, fb34f03 antikoerper, wu:fb34f03 antikoerper, zgc:110525 antikoerper, rbm8-A antikoerper, rbm8a-A antikoerper, rbm8-B antikoerper, RNA binding motif protein 8A antikoerper, RNA binding motif protein 8a antikoerper, RNA binding motif protein 8A S homeolog antikoerper, RNA binding motif protein 8A L homeolog antikoerper, RBM8A antikoerper, Rbm8a antikoerper, rbm8a antikoerper, rbm8a.S antikoerper, rbm8a.L antikoerper

Hintergrund: Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon junction in the mature mRNA for the gene expression machinery and the core components remain bound to spliced mRNAs throughout all stages of mRNA metabolism thereby influencing downstream processes including nuclear mRNA export, subcellular mRNA localization, translation efficiency and nonsense-mediated mRNA decay (NMD). The MAGOH-RBM8A heterodimer inhibits the ATPase activity of EIF4A3, thereby trapping the ATP- bound EJC core onto spliced mRNA in a stable conformation. The MAGOH-RBM8A heterodimer interacts with the EJC key regulator WIBG/PYM leading to EJC disassembly in the cytoplasm and translation enhancement of EJC-bearing spliced mRNAs by recruiting them to the ribosomal 48S preinitiation complex. Its removal from cytoplasmic mRNAs requires translation initiation from EJC-bearing spliced mRNAs. Associates preferentially with mRNAs produced by splicing. Does not interact with pre-mRNAs, introns, or mRNAs produced from intronless cDNAs. Associates with both nuclear mRNAs and newly exported cytoplasmic mRNAs. The MAGOH-RBM8A heterodimer is a component of the nonsense mediated decay (NMD) pathway. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes), specifically inhibits formation of proapoptotic isoforms such as Bcl-X(S), the function is different from the established EJC assembly.

Molekulargewicht: 19889

UniProt: Q9Y5S9